Search Within

Sergio Andres Giralt

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (8)
  3. Correspondence (1)
  4. Research Letter (1)
Groups
  1. Bone Marrow Transplant (22)
  2. Center for Hematologic Malignancies (22)
  3. Department of Medicine (22)
  4. Hematologic Malignancies, Division of (22)
  5. Molecular Imaging and Therapy Service (22)
  6. Radiology, Department of (22)

More Groups

People
  1. Sean Devlin (16)
  2. Gunjan Shah (14)
  3. Michael Scordo (13)
  4. Miguel-Angel Perales (13)
  5. Parastoo Dahi (11)
  6. Heiko Schoder (9)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (5)
  4. 2022 (2)
  5. 2021 (2)
  6. 2020 (5)

More Years

Publications
  1. Blood (7)
  2. Bone Marrow Transplantation (3)
  3. Hematological Oncology (2)
  4. Leukemia and Lymphoma (2)
  5. Biology of Blood and Marrow Transplantation (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. Nature Publishing Group (4)
  3. Elsevier Inc. (3)
  4. Taylor & Francis Group (2)
  5. Wiley Blackwell (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (22)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I trial of MCARH109, a G protein-coupled receptor class C group 5 member D (GPRC5D)-targeted chimeric antigen receptor T-cell therapy for multiple myeloma: An updated analysis
    Journal Article

    Jurgens, E. M.; Firestone, R. S.; Chaudhari, J.; Hosszu, K.; Devlin, S. M.; Shah, U. A.; Landa, J.; McAvoy, D. P.; Lesokhin, A. M.; Korde, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Phase I trial of MCARH109, a first-in-class G Protein Coupled Receptor Class C Group 5 Member D (GPRC5D)-targeted CAR T-cell therapy for relapsed or refractory multiple myeloma: Updated analysis
    Meeting Abstract

    Jurgens, E.; Firestone, R.; Chaudhari, J.; Hosszu, K.; Devlin, S.; Shah, U.; Landa, J.; McAvoy, D.; Lesokhin, A.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Metabolic tumor volume response after bridging therapy determines chimeric antigen receptor T-cell outcomes in large B-cell lymphoma
    Journal Article

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G.; Fregonese, B.; Wills, B.; Bedmutha, A.; Alarcon Tomas, A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • High-dose targeted radiation with (131)I-apamistamab prior to HCT demonstrated a dose-response for durable complete remission in patients with R/R AML
    Meeting Abstract

    Litzow, M. R.; Chen, G.; Gyurkocza, B.; Nath, R.; Seropian, S.; Choe, H.; Abboud, C. N.; Koshy, N.; Tomlinson, B. K.; Abhyankar, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Post-transplant pain and paralysis: Neurologic amyotrophy as an atypical cause of shoulder dysfunction following hematopoietic stem cell transplant
    Meeting Abstract

    Davidoff, C.; Ibanez, K.; Hwang, S.; Goldstein, I.; Feldman, D. R.; Gyurkocza, B.; Giralt, S. A.; Politikos, I.; Ponce, D. M.; Scordo, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J. R.; Devlin, S. M.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Wills, B.; Tomas, A. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T‐cell therapy outcome
    Meeting Abstract

    Imber, B. S.; Silverman, E. A.; Leithner, D.; Hubbeling, H.; Shah, G. L.; Fregonese, B.; Sanin, B. W.; Tomas, A. A.; Parascondola, A.; Saldia, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • GPRC5D-targeted CAR T cells for myeloma
    Journal Article

    Mailankody, S.; Devlin, S. M.; Landa, J.; Nath, K.; Diamonte, C.; Carstens, E. J.; Russo, D.; Auclair, R.; Fitzgerald, L.; Cadzin, B.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Ionizing radiation exposure after allogeneic hematopoietic cell transplantation
    Correspondence

    Cho, C.; Maloy, M. A.; Devlin, S. M.; Aras, O.; Dauer, L. T.; Jakubowski, A. A.; Papadopoulos, E. B.; Perales, M. A.; Rappaport, T. S.; Giralt, S. A.
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save